ICD-10 Coding for Myeloproliferative Disease(C92.1, C92.1P, C94.4)
Explore the ICD-10 coding for myeloproliferative disease, including documentation requirements and common coding pitfalls.
Complete code families applicable to Myeloproliferative Disease
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D47.1 | Chronic myeloproliferative disease | Use when a specific subtype of myeloproliferative disease is not identified. |
|
| C94.4 | Polycythemia vera | Use when polycythemia vera is confirmed by clinical and laboratory findings. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMyeloproliferative Disease
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Myeloproliferative Disease.
Failing to document genetic test results.
Impact
Clinical: Inaccurate diagnosis and treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation
Ensure all genetic test results are included in the patient's medical record.
Using D47.1 for specific subtypes like polycythemia vera.
Impact
Reimbursement: Incorrect reimbursement due to misclassification., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use specific codes like C94.4 for polycythemia vera.
Genetic Testing Documentation
Impact
Lack of genetic test documentation can lead to audit risks.
Mitigation
Ensure all genetic test results are documented in the patient's record.